Biomanufacturing can speed production of a low-glycemic sweetener—and may unlock its commercial potential, Tufts researchers say.
Imagine a sugar that has only 38 percent of the calories of traditional table sugar, is safe for diabetics, and will not cause cavities. Now add that this dream sweetener is not an artificial substitute but a real sugar found in nature and it tastes like, well, sugar. You’d probably want to use that in your next cup of coffee, right?
This sugar is called tagatose. The FDA has approved it as a food additive, and there have been no reports to date of the problems that many sugar substitutes have—such as a metallic taste, or worse, links to cancer—according to researchers and the FAO/WHO, which certified the sugar as “generally regarded as safe.”
So why isn’t it in all your favorite desserts? The answer lies in the expense of producing it. While derived from fruits and dairy products, tagatose is not abundant and is difficult to extract from those sources. The manufacturing process involves a conversion from more easily obtained galactose to tagatose and is highly inefficient, with yields that may reach only 30 percent.
But researchers at Tufts University have developed a process that may unlock the commercial potential of this low-calorie, low-glycemic sugar. In a recent publication in Nature Communications, Assistant Professor Nikhil Nair and postdoctoral fellow Josef Bober, both from the School of Engineering, came up with an innovative way to produce the sugar using bacteria as tiny bioreactors that encapsulate the enzymes and reactants.
Using this approach, they achieved yields up to 85 percent. Although there are many steps from the lab to commercial production, yields this high could lead to large-scale manufacturing and getting tagatose on every supermarket shelf.
The enzyme of choice to make tagatose from galactose is called L-arabinose isomerase (LAI). However, galactose is not the main target for the enzyme, so the rates and yields of the reaction with galactose are less than optimal.
In a solution, the enzyme itself is not very stable, and the reaction can only push forward until about 39 percent of the sugar is converted to tagatose at 37 degrees Celsius (about 99 degrees Fahrenheit), and only up to 16 percent at 50 degrees Celsius (about 122 degrees Fahrenheit), before the enzyme degrades.
Nair and Bober looked to overcome each of those hurdles through biomanufacturing, using Lactobacillus plantarum—a food-safe bacterium—to make large quantities of the LAI enzyme and keep it safe and stable within the confines of the bacterial cell wall.
They found that when expressed in L. plantarum, the enzyme kept converting galactose to tagatose and pushed the yield to 47 percent at 37 degrees Celsius. But now that the LAI enzyme was stabilized within the cell, it could increase yield to 83 percent at the higher temperature of 50 degrees Celsius without degrading significantly, and it was producing tagatose at a much faster rate.
To determine if they could push the reaction even faster, Nair and Bober examined what might still be limiting it. They found evidence that the transport of the starting material, galactose, into the cell was a limiting factor. To resolve that issue, they treated the bacteria with very low concentrations of detergents—just enough to make their cell walls leaky, according to the researchers. The galactose was able to get in and tagatose released from the cells, allowing the enzyme to convert galactose to tagatose at a faster rate, shaving a couple hours off the time needed to get to 85 percent yield at 50 degrees Celsius.
“You can’t beat thermodynamics. But while that’s true, you can circumvent its limitations by engineering solutions,” said Nair, who is corresponding author of the study. “This is like the fact that water will not naturally flow from lower elevation to higher elevation because thermodynamics won’t allow it. However, you can beat the system by, for example, using a siphon, which pulls the water up first before letting it out the other end.”
Encapsulating the enzyme for stability, running the reaction at higher temperature, and feeding it more starting material through leaky cell membranes are all “siphons” used to pull the reaction forward.
Although more work is needed to determine if the process can be scaled up to commercial applications, biomanufacturing has the potential to improve yields and have an impact on the sweetener substitute market, which was estimated to be worth $7.2 billion in 2018, according to the market research firm Knowledge Sourcing Intelligence.
Nair and Bober also note that there are many other enzymes that can benefit from using bacteria as tiny chemical reactors that increase enzyme stability for high temperature reactions and improve rates and yields of conversion and synthesis. As they look ahead to exploring other applications, from the manufacture of food ingredients to plastics, there will be a lot on their plate.
Learn more: Bacteria Help Make Low-Calorie Sugar
The Latest Google Headlines on:
The Latest Bing News on:
- FDA Denies Request to Exempt D-Tagatose from Added Sugar Labelingon May 24, 2022 at 1:40 pm
In a letter dated May 18, 2022, FDA denied a citizen petition from Bonumose LLC which requested that the Agency (1) exempt D-tagatose from classification as an “Added S ...
- Bonumose says FDA Sides With High Fructose Corn Syrup Producers and Against Consumers, By Suppressing Truthful Information About Tagatoseon May 19, 2022 at 9:11 am
Tagatose – a naturally-occurring sugar replacement – acts like dietary fiber in the human gut, feeds good gut bacteria, and contributes to gut health, which is associated with increased ...
- Bonumose says FDA Sides With High Fructose Corn Syrup Producers and Against Consumers, By Suppressing Truthful Information About Tagatoseon May 19, 2022 at 9:00 am
Advisor Insights Personal Finance Market Volatility Retirement Planning Start Investing Save for College Best Investments See All ...
The Latest Google Headlines on:
The Latest Bing News on:
- Stevia Market is expected to reach the value of 1092 million USD by the end of 2027on May 24, 2022 at 2:50 am
Stevia is a non-cariogenic, calorie-free sweetener with a low glycemic index (GI). It has numerous potential benefits, including diabetic and obese treatment, blood pressure control, and weight ...
- Allulose Market Size Worth US$ 362.24Mn, Globally, by 2028 at 6.5% CAGR - Exclusive Report by The Insight Partnerson May 20, 2022 at 11:15 pm
The growing importance of allulose as a low-calorie sweetener is driving its demand in the ... products and dietary supplements due to its low calorie count and low glycemic index. Allulose is ...
- Alternative Sweeteners Market [REVENUE SOURCE] New Opportunities, Product Analysis, and Application, Forecast 2022 – 2030on May 18, 2022 at 7:45 am
These sweeteners have a low glycemic index that keeps the insulin levels unaffected after their consumption, and thus, are used as food additives. Variants of alternative sweeteners are being ...
- Replacing sweeteners creates formulation challengeson May 17, 2022 at 6:59 am
Replacing a sweetener in a formulation may mean substituting one high-calorie sweetener with another, swapping out low-calorie options, or reducing the calorie count in a baked item by replacing a ...
- Stevia Market Share Growing at 8.0% CAGR – Global and Regional Analysison May 13, 2022 at 1:46 am
Download Sample Copy Of [email protected] https://www.alliedmarketresearch.com/request-sample/6407 Stevia is a non-nutritive natural sweetener, which has low or no calorie, low glycemic index, and is ...
- I've Never Liked Zero-Calorie Sweeteners, But This One Blew Me Awayon May 11, 2022 at 7:45 am
Recently, though, I had the opportunity to try the zero-calorie, low-glycemic sugar alternative ... (Check out our explainer on alternative sweeteners' safety.) So what exactly is Purecane ...
- I've Never Liked Zero-Calorie Sweeteners, But This One Blew Me Awayon May 11, 2022 at 7:02 am
Although this nutritionist has never been a big fan of sugar alternatives, this zero-calorie sweetener left her pleasantly surprised.
- Allulose Market Size Worth US$ 362.24Mn, Globally, by 2028 at 6.5% CAGR - Exclusive Report by The Insight Partnerson April 25, 2022 at 6:11 am
The growing importance of allulose as a low-calorie sweetener is driving its demand ... supplements due to its low calorie count and low glycemic index. Allulose is suitable for people with ...